| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.096 | 0.02 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.02 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.03 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.03 |